Share This Article:

Determination of 8 Diuretics and Probenecid in Human Urine by Gas Chromatography-Mass Spectrometry: Confirmation Procedure

Abstract Full-Text HTML Download Download as PDF (Size:553KB) PP. 320-327
DOI: 10.4236/ajac.2012.34044    4,534 Downloads   8,234 Views   Citations

ABSTRACT

A fast and sensitive method for determination of 8 diuretics (acetazolamide, bendroflumethiazide, bumetanide, chlorthalidone, furosemide, hydrochlorothiazide, metolazone, triamterene) and masking agent (probenecid) in human urine using gas-chromatography with mass spectrometric detection is described. The extraction of the substances as function of the nature of organic solvent, mixing time and pH of aqueous phase was studied. The tandem mass spectrometry was used to increase selectivity of diuretics determination due to elimination of background interferences. Fragmentation reactions were studied for each compound and their collision energies were optimized to obtain the best selectivity. The results of method’s validation demonstrate its suitability in routine analysis for confirmation purposes.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

O. Zaporozhets, I. Tsyrulneva and M. Ischenko, "Determination of 8 Diuretics and Probenecid in Human Urine by Gas Chromatography-Mass Spectrometry: Confirmation Procedure," American Journal of Analytical Chemistry, Vol. 3 No. 4, 2012, pp. 320-327. doi: 10.4236/ajac.2012.34044.

References

[1] WADA, “The world Anti-Doping Code—the 2009 Prohibited List: International Standard,” World Anti-Doping Agency, Montreal, 2009.
[2] WADA, “Minimum Required Performance Limits for Detection of Prohibited Substances (Technical Document TD2009MRPL),” World Anti-Doping Agency, Montreal, 2009.
[3] R. Ventura and J. Segura, “Detection of Diuretic Agents in Doping Control,” Journal of Chromatography B, Vol. 687, No. 1, 1996, pp. 127-144. doi:10.1016/S0378-4347(96)00279-4
[4] M. Mazzarino, X. de la Torre and F. Botrè, “A Screening Method for the Simultaneous Detection of Glucocorti-coids, Diuretics, Stimulants, Anti-Estrogens, Beta-Adrenergic Drugs and Anabolic Steroids in Human Urine by LC-ESI-MS/MS,” Analytical and Bioanalytical Chemistry, Vol. 392, No. 4, 2008, pp. 681-698. doi:10.1007/s00216-008-2292-5
[5] O. J. Pozo, P. Van Eenoo, K. Deventer and F. T. Delbeke, “Development and Validation of a Qualitative Screening Method for the Detection of Exogenous Anabolic Steroids in Urine by liquid Chromatography-Tandem Mass Spectrometry,” Analytical and Bioanalytical Chemistry, Vol. 389, No. 4, 2007, pp. 1209-1224. doi:10.1007/s00216-007-1530-6
[6] K. Deventer, O. J. Pozo, P. Van Eenoo and F. T. Delbeke, “Qualitative Detection of Diuretics and Acidic Metabolites of Other Doping Agents in Human Urine by High-Performance Liquid Chromatography-Tandem Mass Spectrometry. Comparison between Liquid-Liquid Extraction and Direct Injection,” Journal of Chromatography A, Vol. 1216, No. 31, 2009, pp. 5819-5827. doi:10.1016/j.chroma.2009.06.003
[7] R. Ventura, M. Roig, N. Monfort, P. Saez, R. Berges and J. Segura, “High-Throughput and Sensitive Screening by Ultra-Performance Liquid Chromatography Tandem Mass Spectrometry of Diuretics and Other Doping Agents,” European Journal of Mass Spectrometry, Vol. 14, No. 3, 2008, pp. 191-200. doi:10.1255/ejms.920
[8] V. Morra, P. Davit and P. Capra, “Fast Gas Chromatographic/Mass Spectrometric Determination of Diuretics and Masking Agents in Human Urine. Development and Validation of a Productive Screening Protocol for Anti-doping Analysis,” Journal of Chromatography A, Vol. 1135, No. 2, 2006, pp. 219-229. doi:10.1016/j.chroma.2006.09.034
[9] L. Amendola, C. Colamonici, M. Mazzarino and F. Botrè, “Rapid Determination of Diuretics in Human Urine by Gas Chromatography-Mass Spectrometry Following Micro- wave Assisted Derivatization,” Analytica Chimica Acta, Vol. 475, No. 1-2, 2003, pp. 125-136. doi:10.1016/S0003-2670(02)01223-0
[10] C. Brunelli, C. Bicchi, A. Di Stilo, A. Salomone and M. Vincenti, “High-Speed Gas Chromatography in Doping Control: Fast-GC and Fast-GC/MS Determination of β- Adrenoceptor Ligands and Diuretics,” Journal of Separation Science, Vol. 29, No. 18, 2006, pp. 2765-2771. doi:10.1002/jssc.200500387
[11] Y.-L. Tseng, M.-H. Shieh, C.-T. Lin and F.-H. Kuo, “Detection of Diuretics in Urine during Sports Events in Taiwan,” Tzu Chi Medical Journal, Vol. 16, No. 2, 2004, pp. 69-77.
[12] P. Van Eenoo and F. T. Delbeke, “Criteria in Chromatography and Mass-Spectrometry—A Comparison between Regulations in the Field of Residue and Doping Analysis,” Chromatographia, Vol. 59, Suppl. 1, 2004, pp. 39- 44. doi:10.1365/s10337-004-0198-8
[13] L. Politi, L. Morini and A. Polettini, “A Direct Screening Procedure for Diuretics in Human Urine by Liquid Chromatography-Tandem Mass Spectrometry with Information Dependent Acquisition,” Clinica Chimica Acta, Vol. 386, No. 1-2, 2007, pp. 46-52. doi:10.1016/j.cca.2007.07.018
[14] C. Goebel, G. Trout and R. Kazlauskas, “Rapid Screening Method for Diuretics in Doping Control Using Auto-mated Solid Phase Extraction and Liqud Chromatography-Electrospray Tandem Mass Spectrometry,” Analytica Chimica Acta, Vol. 502, No. 1, 2004, pp. 65-74. doi:10.1016/j.aca.2003.09.062
[15] D. Thieme, J. Grosse, R. Lang, R. K. Mueller and A. Wahl, “Screening, Confirmation an Quantification of Diuretics in Urine for Doping Control Analysis by High-Perform- ance Liquid Chromatography-Atmospheric Pressure Ionization Tandem Mass Spectrometry,” Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 757, No. 1, 2001, pp. 49-57. doi:10.1016/S0378-4347(01)00058-5
[16] S. J. Park, H. S. Pyo, Y. J. Kim, M. S. Kim and J. Park, “Systematic Analysis of Diuretic Doping Agents by HPLC Screening and GC/MS Confirmation,” Journal of Analytical Toxicology, Vol. 14, No. 2, 1990, pp. 84-90.
[17] ISO/IEC 17025, “General Requirements for the Competence of Testing and Calibration Laboratories,” 2006.
[18] Eurachem Working Group, “A Laboratory Guide to Method Validation and Related Topics,” Eurachem, Teddington, 1998.
[19] WADA, “The International Standard for Laboratories, Version 6.0,” World Anti-Doping Agency, Montreal, 2009.
[20] E. Hoffmann and V. Stroobant, “Mass Spectrometry. Principles and Applications,” 3rd Edition, WILEY-VCH Ver- lag GmbH & Co. KGaA, Weinheim, 2007.
[21] WADA, “Identification Criteria for Qualitative Assays Incorporating Column Chromatography and Mass Spectrometry (Number TD2010IDCR),” World Anti-Doping Agency, Montreal, 2010.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.